Antiverse pricing
Nxera pays Antiverse an upfront sum, research funding and milestones, and reported no material financial impact from the agreement for 2024. Amounts for that deal and for the GlobalBio and Cystic Fibrosis Foundation collaborations are undisclosed, and equity raised is the only figure the company has announced.
How Antiverse pricing works
- Pricing model
- Paid through research and licensing partnerships: an upfront payment, research funding during the program and milestone payments, with the partner usually licensing the resulting antibodies. No platform license or subscription is sold.
- Implementation
- Programs run in house, and the laboratory work behind them is covered by research funding from the partner, as in the Nxera agreement, so no implementation fee applies.
Antiverse pricing against its alternatives
Published prices for Antiverse and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- AAntiverseNo published price
- NNabla BioNo published price
- AAbsciNo published price
- SSuperluminal MedicinesNo published price
- BBiolojic DesignNo published price
- IimmunitoAINo published price
- CChai DiscoveryNo published price
- MMolcureNo published price
- PProfluentOpenCRISPR-1 free to license, other terms not published
Antiverse pricing, answered
How much does Antiverse cost?
Antiverse does not publish a price. Nxera pays Antiverse an upfront sum, research funding and milestones, and reported no material financial impact from the agreement for 2024. Amounts for that deal and for the GlobalBio and Cystic Fibrosis Foundation collaborations are undisclosed, and equity raised is the only figure the company has announced.
Does Antiverse charge an implementation fee?
Programs run in house, and the laboratory work behind them is covered by research funding from the partner, as in the Nxera agreement, so no implementation fee applies.